New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
The emergence of multi-drug (MDR-TB) and extensively-drug resistant tuberculosis (XDR-TB) is a major threat to the global management of tuberculosis (TB) worldwide. New chemical entities are of need to treat drug-resistant TB. In this study, the mode of action of new, potent quinazoline derivatives...
Saved in:
Main Authors: | Lupien, Andréanne, Foo, Caroline Shi-Yan, Savina, Svetlana, Vocat, Anthony, Piton, Jérémie, Monakhova, Natalia, Benjak, Andrej, Lamprecht, Dirk A., Steyn, Adrie J. C., Pethe, Kevin, Makarov, Vadim A., Cole, Stewart T. |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/146858 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of Mycobacterium tuberculosis
by: Foo, Caroline S., et al.
Published: (2019) -
Oxidative phosphorylation — an update on a new, essential target space for drug discovery in mycobacterium tuberculosis
by: Foo, Caroline Shi-Yan, et al.
Published: (2020) -
Allosteric pyruvate kinase-based “logic gate” synergistically senses energy and sugar levels in Mycobacterium tuberculosis
by: Zhong, Wenhe, et al.
Published: (2018) -
EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
by: Ang, Michelle L. T., et al.
Published: (2017) -
Studies on dihydrofolate reductase from mycobacterium smegmatis
by: Atid Chanpongsri
Published: (2023)